NASDAQ:CAC - Camden National Stock Price, Forecast & News

Camden National trades on the NASDAQ under the ticker symbol "CAC."

Camden National declared a quarterly dividend on Tuesday, December 17th. Investors of record on Wednesday, January 15th will be given a dividend of $0.33 per share on Friday, January 31st. This represents a $1.32 annualized dividend and a dividend yield of 2.81%. The ex-dividend date is Tuesday, January 14th. This is a boost from Camden National's previous quarterly dividend of $0.30. View Camden National's Dividend History.

Camden National Co. (NASDAQ:CAC) issued its quarterly earnings data on Tuesday, January, 28th. The financial services provider reported $0.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.89 by $0.10. The financial services provider had revenue of $44.19 million for the quarter, compared to analyst estimates of $42.16 million. Camden National had a return on equity of 12.35% and a net margin of 27.16%. View Camden National's Earnings History.

Camden National is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Camden National.

2 Wall Street analysts have issued 1-year target prices for Camden National's shares. Their forecasts range from $48.00 to $48.00. On average, they expect Camden National's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 2.1% from the stock's current price. View Analyst Price Targets for Camden National.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Camden National in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Camden National.

News articles about CAC stock have trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Camden National earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the company's share price in the immediate future. View News Stories for Camden National.

Camden National saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 345,700 shares, an increase of 5.0% from the December 31st total of 329,200 shares. Based on an average daily trading volume, of 45,600 shares, the short-interest ratio is currently 7.6 days. Currently, 2.3% of the shares of the company are short sold. View Camden National's Current Options Chain.

Some companies that are related to Camden National include PNC Financial Services Group (PNC), Truist Financial (TFC), SunTrust Banks (STI), M&T Bank (MTB), Fifth Third Bancorp (FITB), First Republic Bank (FRC), KeyCorp (KEY), Regions Financial (RF), Huntington Bancshares (HBAN), SVB Financial Group (SIVB), Commerce Bancshares (CBSH), Signature Bank (SBNY), Zions Bancorporation NA (ZION), East West Bancorp (EWBC) and TCF Financial (TCF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Camden National investors own include Pattern Energy Group (PEGI), AbbVie (ABBV), Chewy (CHWY), AT&T (T), Verizon Communications (VZ), Exxon Mobil (XOM), Century Aluminum (CENX), Netflix (NFLX), RealReal (REAL) and Stitch Fix (SFIX).

Camden National's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (6.95%), Royce & Associates LP (3.34%), Renaissance Technologies LLC (3.22%), LSV Asset Management (2.40%), State Street Corp (2.11%) and Geode Capital Management LLC (1.39%). Company insiders that own Camden National stock include Carl John Soderberg, Deborah A Jordan, Gregory A Dufour, Joanne T Campbell and Marie J Mccarthy. View Institutional Ownership Trends for Camden National.

CAC stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, FMR LLC, Prudential Financial Inc., Minerva Advisors LLC, New York State Common Retirement Fund, Rothschild & Co. Asset Management US Inc., IndexIQ Advisors LLC and Chicago Equity Partners LLC. Company insiders that have sold Camden National company stock in the last year include Gregory A Dufour and Joanne T Campbell. View Insider Buying and Selling for Camden National.

CAC stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Acadian Asset Management LLC, Royce & Associates LP, Bank of New York Mellon Corp, Public Sector Pension Investment Board, Hotchkis & Wiley Capital Management LLC, State Street Corp and Oxford Asset Management LLP. Company insiders that have bought Camden National stock in the last two years include Carl John Soderberg, Deborah A Jordan, Gregory A Dufour, Joanne T Campbell and Marie J Mccarthy. View Insider Buying and Selling for Camden National.

Shares of CAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CAC stock can currently be purchased for approximately $47.02.

Camden National has a market capitalization of $714.23 million and generates $210.63 million in revenue each year. The financial services provider earns $57.20 million in net income (profit) each year or $3.69 on an earnings per share basis. Camden National employs 634 workers across the globe.View Additional Information About Camden National.

The official website for Camden National is http://www.camdennational.com/.

Camden National's mailing address is 2 ELM STREET, CAMDEN ME, 04843. The financial services provider can be reached via phone at 207-236-8821 or via email at [email protected]